For the Inventor, By the Inventor

Enter assignee name

Culver City, CA, United States of America

Nantomics, LLC

USPTO Granted Patents = 66

CIPO Patents = 1

EPO Patents = 18

Forward Citations = 147

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Stephen Charles Benz (32 out of 57 patents)

Shahrooz Rabizadeh (31 out of 86 patents)

Patrick Soon-Shiong (25 out of 475 patents)

4. Kayvan R Niazi (16 out of 99 patents)

5. John Zachary Sanborn (15 out of 63 patents)

6. Andrew Nguyen (15 out of 183 patents)

7. Bing Song (14 out of 79 patents)

8. Christopher W Szeto (13 out of 14 patents)

9. Liudmila A Beziaeva (11 out of 11 patents)

10. Charles Joseph Vaske (9 out of 33 patents)

11. Mustafa Jaber (9 out of 22 patents)

12. Nicholas James Witchey (5 out of 160 patents)

13. Kamil A Wnuk (5 out of 47 patents)

14. Rahul Chaturvedi (4 out of 19 patents)

15. Paul Weingarten (4 out of 10 patents)

Core Competencies:

HLA Tissue Matching

Deep Learning Models

Tumor Evaluation

Viral Neoepitopes

Synthetic Genomic Variants

Digital Histopathology

Cancer Score

Immunotherapy Markers

RNA Stabilization

Genomic Analysis

Adaptive Immunotherapy

Pathology Image Analysis

66 patents: Sort by Forward Citations

1. 12676208 - TUMOR ANTIGENICITY PROCESSING AND PRESENTATION (2026-07-07),

2. 12614612 - HLA tissue matching and methods therefor (2026-04-28),

3. 12518214 - Distributed machine learning systems including generation of synthetic data (2026-01-06),

4. 12487240 - Tumor HLA mutation versus matched normal HLA (2025-12-02),

5. 12412639 - Method of characterizing a tumor based on an immune gene expression signature in regulatory T cell (Treg)-enriched tumor samples (2025-09-09),

6. 12406366 - Real-time whole slide pathology image cell counting (2025-09-02),

7. 12404490 - AGGF1 immunogenic compositions (2025-09-02),

8. 12224066 - Deep learning models for region of interest determination (2025-02-11),

9. 12224064 - Deep learning models for tumor evaluation (2025-02-11),

10. 12205678 - Genome explorer system to process and present nucleotide variations in genome sequence data (2025-01-21),

11. 12205033 - Weakly supervised learning with whole slide images (2025-01-21),

12. 12195808 - Dynamic changes in circulating free RNA of neural tumors (2025-01-14),

13. 12170142 - Classification based on characterization analysis methods and systems (2024-12-17),

14. 12094574 - Difference-based genomic identity scores (2024-09-17),

15. 12080382 - Viral neoepitopes and uses thereof (2024-09-03),

NantOmics, LLC, is a leading precision medicine company dedicated to transforming cancer care through innovative molecular diagnostics. They develop and provide cutting-edge molecular testing and bioinformatics services to help physicians and researchers understand and treat cancer more effectively. With a focus on personalized medicine, NantOmics uses advanced sequencing technologies and artificial intelligence to analyze the molecular profile of tumors and provide actionable insights for personalized treatment decisions. They are committed to revolutionizing cancer care and improving patient outcomes through their state-of-the-art technologies and expertise.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

66 Patents

#5 in Culver City, CA

#1,287 in California

#5,518 in US

#11,144 in the World

Culver City, CA, United States of America

Nantomics, LLC

Forward Citations = 147

40 inventors:

Stephen Charles Benz (32 out of 57 patents)

Shahrooz Rabizadeh (31 out of 86 patents)

Patrick Soon-Shiong (25 out of 475 patents)

4. Kayvan R Niazi (16 out of 99 patents)

5. John Zachary Sanborn (15 out of 63 patents)

Please report any incorrect information to [email protected]

Loading…